Clinical Trials Logo

Filter by:
NCT ID: NCT00084058 Completed - HIV Infections Clinical Trials

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

Start date: n/a
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the effect of increased doses of lopinavir/ritonavir (LPV/r) and saquinavir (SQV) in HIV infected children who are failing their current antiretroviral regimen

NCT ID: NCT00086034 Completed - Lymphoma Clinical Trials

Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma

Start date: n/a
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to find out if motexafin gadolinium may be an effective treatment for patients with non-Hodgkin's lymphoma (NHL). Secondly, the safety and side effects of motexafin gadolinium will be evaluated.

NCT ID: NCT00086112 Completed - Anxiety Disorders Clinical Trials

Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to determine the effectiveness of risperidone as an adjunctive treatment in patients with GAD who demonstrate a less-than-optimal response to their current anxiolytic treatment.

NCT ID: NCT00086203 Completed - Clinical trials for Chronic Lymphocytic Leukemia

Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)

Start date: n/a
Phase: Phase 2
Study type: Interventional

The objective of this study is to assess the efficacy and safety of talabostat and rituximab in patients with advanced CLL who failed to respond, or have progressed following a prior response, to a fludarabine regimen.

NCT ID: NCT00086710 Completed - HIV Infections Clinical Trials

Study of Enfuvirtide in HIV-Positive Subjects

Start date: n/a
Phase: Phase 1
Study type: Interventional

A total of 26 patients will be admitted to the clinic where they will be dosed with each injection device. There will be a 7-day washout between doses and a 7-10 day follow-up period.

NCT ID: NCT00087737 Completed - Clinical trials for Major Depressive Disorder

Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder

Start date: n/a
Phase: Phase 3
Study type: Interventional

To compare the antidepressant efficacy and safety of DVS-233 SR versus placebo in adult outpatients with MDD.

NCT ID: NCT00089869 Completed - Schizophrenia Clinical Trials

A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia

Start date: n/a
Phase: Phase 1/Phase 2
Study type: Interventional

Study of a medication for the treatment of Schizophrenia in patients who are already taking Abilify, Risperdal, Seroquel, Zyprexa

NCT ID: NCT00090649 Completed - Clinical trials for Major Depressive Disorder

Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder

Start date: n/a
Phase: Phase 3
Study type: Interventional

To compare the antidepressant efficacy and safety of DVS-233 SR with those of placebo in adult outpatients with MDD.

NCT ID: NCT00091416 Completed - HIV Infections Clinical Trials

Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052

Start date: n/a
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test the safety of and immune response to an HIV-1 vaccine, VRC-HIVADV014-00-VP, when given as a vaccine booster to HIV uninfected adults who participated in HVTN 052.

NCT ID: NCT00091702 Completed - HIV Infections Clinical Trials

Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents

Start date: n/a
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to compare two flu vaccines to determine their safety and ability to stimulate an immune response in HIV infected children and adolescents. This study will also determine how often and how long people who receive a vaccine are able to spread flu vaccine virus to other people.